<DOC>
	<DOCNO>NCT02073110</DOCNO>
	<brief_summary>Data American Cancer Society show 70 % increase incidence kidney renal pelvis cancer 2000 2010 . This increase attribute small renal mass ( SRM ) incidentally discover abdominal radiological imaging . However , 30 % resected SRMs appear benign histological examination . Conventional biopsy currently use provide pathological information prior resection . However , non-diagnostic value high , 33 % SRMs , show need diagnostic improvement . The investigator show optical biopsy ( OB ) differentiate malignant benign tissue tumor subtypes . However , translation clinic require phase 2 clinical study . The investigator use OB probe combine needle puncture classical biopsy procedure , additionally provide real time micro-scale image contain quantitative information tissue property . The investigator convince OB greatly improve diagnosis renal tumor pathology .</brief_summary>
	<brief_title>Optical Biopsy Improve Diagnosis Kidney Cancer</brief_title>
	<detailed_description>Rationale : Renal biopsy use patient renal mass lesion diagnose whether concern malignant benign mass . In case malignancy , surgery follow step . However , 7 33 % biopsy non-diagnostic , result unnecessary surgery ( even 30 % small renal mass ) . The investigator think optical biopsy ( OB ) , new diagnostic tool base absorption en reflection light tissue , reduce non-diagnostic biopsy rate . This could direct impact quality life patient therefore schedule unnecessary surgical procedure . Also , concern overtreatment lead concept focal therapy , selective patient tailor nephron spar surgical ablation technique lesion , reduce lifetime morbidity side effect without compromise life expectancy . For novel form treatment , accurate identification , grade demarcation lesion crucial OB ideal platform provide approach improved cure . Objectives : Primary - The accuracy DRS OCT diagnostic renal malignancy Secondary - The accuracy DRS OCT diagnostic renal malignancy distinguish among 3 main RCC subtypes - The accuracy combination DRS OCT Study design : This prospective , observational , multi-centre in-vivo study . Study population : Patients ≥ 18 year age , solid enhance renal mass suspect renal cell carcinoma ( RCC ) candidate active ( surgical ) treatment renal mass . Intervention : Patients receive ultrasound guide percutaneous OB follow Core biopsy ( CB ) procedure . The planned institutional surgical protocol follow irrespective result OB CB . During surgery ( radical/partial , open/laparoscopic , percutaneous ablation ) new set DRS OCT measurement tumor normal tissue perform . Main study parameters/endpoints : 1 . To determine accuracy OB differentiate renal tumor pathology benign tissue mean minimal invasive quantitative DRS OCT. 2 . To determine differentiation capability OCT combine technique distinguish three common RCC sub-types . 3 . To determine whether OB good alternative percutaneous biopsy diagnose renal cancer .</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Age ≥ 18 year Solid , enhance mass cross sectional imaging suspect RCC Scheduled total partial nephrectomy laparoscopic cryoablation . Signed informed consent Patients renal mass candidate active treatment exclude study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Kidney cancer</keyword>
	<keyword>Renal mass</keyword>
	<keyword>Small renal mass</keyword>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>OCT</keyword>
	<keyword>Diffuse Reflectance Spectroscopy</keyword>
	<keyword>DRS</keyword>
	<keyword>Optical Biopsy</keyword>
	<keyword>OB</keyword>
</DOC>